Cargando…
Ex vivo isolated human vessel perfusion system for the design and assessment of nanomedicines targeted to the endothelium
Endothelial cells play a central role in the process of inflammation. Their biologic relevance, as well as their accessibility to IV injected therapeutics, make them a strong candidate for treatment with molecularly‐targeted nanomedicines. Typically, the properties of targeted nanomedicines are firs...
Autores principales: | Lysyy, Taras, Bracaglia, Laura G., Qin, Lingfeng, Albert, Claire, Pober, Jordan S., Tellides, George, Saltzman, W. Mark, Tietjen, Gregory T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237142/ https://www.ncbi.nlm.nih.gov/pubmed/32440561 http://dx.doi.org/10.1002/btm2.10154 |
Ejemplares similares
-
Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells
por: Cui, Jiajia, et al.
Publicado: (2017) -
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2
por: Wang, Chen, et al.
Publicado: (2014) -
Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications
por: Albert, C., et al.
Publicado: (2022) -
Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection
por: Rao, Deepak A., et al.
Publicado: (2008) -
Ex vivo lung perfusion
por: Watanabe, Tatsuaki, et al.
Publicado: (2021)